155 related articles for article (PubMed ID: 33066862)
1. Efficacy of Nardostachys jatamansi (D.Don) DC in essential hypertension: A randomized controlled study.
Bhat MDA; Malik SA
Complement Ther Med; 2020 Sep; 53():102532. PubMed ID: 33066862
[TBL] [Abstract][Full Text] [Related]
2. Secondary metabolite profiling, cytotoxicity, anti-inflammatory potential and in vitro inhibitory activities of Nardostachys jatamansi on key enzymes linked to hyperglycemia, hypertension and cognitive disorders.
Bose B; Tripathy D; Chatterjee A; Tandon P; Kumaria S
Phytomedicine; 2019 Mar; 55():58-69. PubMed ID: 30668444
[TBL] [Abstract][Full Text] [Related]
3. Nardostachys jatamansi (D.Don) DC.-Challenges and opportunities of harnessing the untapped medicinal plant from the Himalayas.
Dhiman N; Bhattacharya A
J Ethnopharmacol; 2020 Jan; 246():112211. PubMed ID: 31533076
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
5. A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi.
Jalali S; Zarrinhaghighi A; Sadraei S; Ghasemi Y; Sakhteman A; Faridi P
Curr Drug Metab; 2018; 19(5):469-476. PubMed ID: 29512454
[TBL] [Abstract][Full Text] [Related]
6. Nardostachys jatamansi: Phytochemistry, ethnomedicinal uses, and pharmacological activities: A comprehensive review.
Pathak S; Godela R
Fitoterapia; 2024 Jan; 172():105764. PubMed ID: 38042505
[TBL] [Abstract][Full Text] [Related]
7. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
8. Effect of Melissa officinalis on systolic and diastolic blood pressures in essential hypertension: A double-blind crossover clinical trial.
Shekarriz Z; Shorofi SA; Nabati M; Shabankhani B; Yousefi SS
Phytother Res; 2021 Dec; 35(12):6883-6892. PubMed ID: 34766389
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PH; Souza ER
Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant activities and regulative effects on serotonin transporter of Nardostachys jatamansi DC.
Li R; Wang ZM; Wang Y; Dong X; Zhang LH; Wang T; Zhu Y; Gao XM; Wu HH; Xu YT
J Ethnopharmacol; 2021 Mar; 268():113601. PubMed ID: 33220358
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T; Himmelmann A
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[TBL] [Abstract][Full Text] [Related]
12. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats.
Subashini R; Ragavendran B; Gnanapragasam A; Yogeeta SK; Devaki T
Pharmazie; 2007 May; 62(5):382-7. PubMed ID: 17557749
[TBL] [Abstract][Full Text] [Related]
13. Six kanshone C-derived sesquiterpenoid hybrids nardochalaristolones A-D, nardoflavaristolone A and dinardokanshone F from Nardostachys jatamansi DC.
Deng X; Wang Y; Wu HH; Zhang W; Dong X; Wang Z; Zhu Y; Gao XM; Li L; Wang YN; Xu YT
Bioorg Chem; 2018 Dec; 81():35-43. PubMed ID: 30092385
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats.
Rao VS; Rao A; Karanth KS
J Ethnopharmacol; 2005 Dec; 102(3):351-6. PubMed ID: 16095854
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.
Razack S; Kandikattu HK; Venuprasad MP; Amruta N; Khanum F; Chuttani K; Mishra AK
Metab Brain Dis; 2018 Oct; 33(5):1533-1549. PubMed ID: 29934858
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
Omboni S; Zanchetti A
J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
[TBL] [Abstract][Full Text] [Related]
17. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia).
Toolika E; Bhat NP; Shetty SK
Ayu; 2015; 36(1):46-9. PubMed ID: 26730138
[TBL] [Abstract][Full Text] [Related]
18. Stability of valeriana-type iridoid glycosides from rhizomes of Nardostachys jatamansi and their protection against H
Ngo TH; Uprety A; Ojha M; Kil YS; Choi H; Kim SY; Nam JW
Phytochemistry; 2022 Nov; 203():113375. PubMed ID: 35973611
[TBL] [Abstract][Full Text] [Related]
19. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension.
Ikeda LS; Harm SC; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1997 Jan; 6(1):35-43. PubMed ID: 9116924
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system depressant activity of
Panara K; Nariya M; Karra N
Ayu; 2020; 41(4):250-254. PubMed ID: 35813358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
